Skip to main content

Advertisement

Log in

MHC class I-LILRB3 delivers a punch to eliminate precancerous cells

  • Research Highlight
  • Published:
Cellular & Molecular Immunology Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Ayukawa S, Kamoshita N, Nakayama J, Teramoto R, Pishesha N, Ohba K, et al. Epithelial cells remove precancerous cells by cell competition via MHC class I-LILRB3 interaction. Nat Immunol. 2021;22:1391–402.

    Article  CAS  Google Scholar 

  2. Martincorena I, Roshan A, Gerstung M, Ellis P, Van Loo P, McLaren S, et al. Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin. Science. 2015;348:880–6.

    Article  CAS  Google Scholar 

  3. Martincorena I, Fowler JC, Wabik A, Lawson ARJ, Abascal F, Hall MWJ, et al. Somatic mutant clones colonize the human esophagus with age. Science. 2018;362:911–7.

    Article  CAS  Google Scholar 

  4. Lee-Six H, Olafsson S, Ellis P, Osborne RJ, Sanders MA, Moore L, et al. The landscape of somatic mutation in normal colorectal epithelial cells. Nature. 2019;574:532–7.

    Article  CAS  Google Scholar 

  5. Geyer RJ, Tobet R, Berlin RD, Srivastava PK. Immune response to mutant neo-antigens: cancer’s lessons for aging. Oncoimmunology. 2013;2:e26382.

    Article  Google Scholar 

  6. Baker NE. Emerging mechanisms of cell competition. Nat Rev Genet. 2020;21:683–97.

    Article  CAS  Google Scholar 

  7. Casey SC, Baylot V, Felsher DW. The MYC oncogene is a global regulator of the immune response. Blood. 2018;131:2007–15.

    Article  CAS  Google Scholar 

  8. de la Cova C, Senoo-Matsuda N, Ziosi M, Wu DC, Bellosta P, Quinzii CM, et al. Supercompetitor status of Drosophila Myc cells requires p53 as a fitness sensor to reprogram metabolism and promote viability. Cell Metab. 2014;19:470–83.

    Article  Google Scholar 

  9. van Neerven SM, de Groot NE, Nijman LE, Scicluna BP, van Driel MS, Lecca MC, et al. Apc-mutant cells act as supercompetitors in intestinal tumour initiation. Nature. 2021;594:436–41.

    Article  Google Scholar 

  10. Flanagan DJ, Pentinmikko N, Luopajärvi K, Willis NJ, Gilroy K, Raven AP, et al. NOTUM from Apc-mutant cells biases clonal competition to initiate cancer. Nature. 2021;594:430–5.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This project was supported by funding from the Research Grants Council-General Research Fund (24100520, 14108718, 14101321), Research Grants Council-Collaborative Research Fund (C4039-19G), and Heath and Medical Research Fund (06170686, 08190706).

Author information

Authors and Affiliations

Authors

Contributions

CCW and JY drafted and revised the paper.

Corresponding authors

Correspondence to Chi Chun Wong or Jun Yu.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wong, C.C., Yu, J. MHC class I-LILRB3 delivers a punch to eliminate precancerous cells. Cell Mol Immunol 19, 655–656 (2022). https://doi.org/10.1038/s41423-021-00821-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41423-021-00821-6

  • Springer Nature Limited

Navigation